Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Beckman Coulter Genomics

Beckman Coulter Genomics
2008 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer and provider of generation sequencing platform. The company offers a range of next generation sequencing services utilizing a combination of Illumina and Roche 454 next generation sequencing platforms.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Social/Platform Software
Discovery Tools (Healthcare)
Acquirer
Primary Office
  • 36 Cherry Hill Drive
  • Danvers, MA 01923
  • United States

+1 (978) 000-0000

Beckman Coulter Genomics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Beckman Coulter Genomics‘s full profile, request access.

Request full access to PitchBook

Beckman Coulter Genomics Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Beckman Coulter Genomics‘s full profile, request access.

Request full access to PitchBook